Clene Inc Stock Analysis

Clene Stock Analysis Notes

About 30.0% of the company shares are held by company insiders. The company recorded a loss per share of 3.44. Clene Inc had not issued any dividends in recent years. The entity had 1:20 split on the 11th of July 2024. Clene Inc., a clinical-stage pharmaceutical company, focuses on the discovery, development, and commercialization of novel clean-surfaced nanotechnology therapeutics. It also markets and distributes dietary supplements comprising rMetx, an aqueous zinc-silver ion dietary supplement and KHC46, an aqueous gold dietary supplement of very low-concentration Au nanoparticles. Clene operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 95 people. For more info on Clene Inc please contact Robert MBA at 801 676 9695 or go to https://clene.com.

Clene Inc Investment Alerts

Clene Inc Upcoming and Recent Events

Clene Largest EPS Surprises

View All Earnings Estimates

Clene Environmental, Social, and Governance (ESG) Scores

Clene Market Capitalization

The company currently falls under 'Micro-Cap' category with a current market capitalization of 88.46 M.

Clene Profitablity

Management Efficiency

Clene Inc has return on total asset (ROA) of (0.5624) % which means that it has lost $0.5624 on every $100 spent on assets. This is way below average. Similarly, it shows a return on stockholder's equity (ROE) of (17.3836) %, meaning that it created substantial loss on money invested by shareholders. Clene's management efficiency ratios could be used to measure how well Clene manages its routine affairs as well as how well it operates its assets and liabilities. As of the 19th of November 2025, Return On Equity is likely to grow to 4.67, though Return On Tangible Assets are likely to grow to (1.37). At this time, Clene's Total Assets are very stable compared to the past year. As of the 19th of November 2025, Net Tangible Assets is likely to grow to about 3.9 M, while Other Current Assets are likely to drop about 2.1 M.

Technical Drivers

As of the 19th of November, Clene shows the risk adjusted performance of 0.1352, and Mean Deviation of 6.51. Clene Inc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm's future prices.

Clene Inc Price Movement Analysis

Clene Inc Insider Trading Activities

Clene Outstanding Bonds

Clene Predictive Daily Indicators

Clene Corporate Filings

Clene Forecast Models

Clene's time-series forecasting models are one of many Clene's stock analysis techniques aimed at predicting future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Clene's historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Stock analysis is the technique used by a trader or investor to examine and evaluate how Clene prices is reacting to, or reflecting on a current market direction and economic conditions. It can be used to make informed decisions about market timing, and when buying or selling Clene shares will generate the highest return on investment. We also built our stock analysis module to help investors to gain an insight into the world economy as a whole, the stock market, thematic ideas. a specific sector, or an individual Stock such as Clene. By using and applying Clene Stock analysis, traders can create a robust methodology for identifying Clene entry and exit points for their positions.

We track the performance of the top 100 financial experts across various large and mid-size financial boutiques. Clene analyst recommendations are determined by taking all analyst recommendations and averaging them as Strong Buy, Buy, Hold, Strong Sell or Sell. There is no one specific way to measure analysis performance other than comparing it to the past results via a very sophisticated attribution analysis. Clene analyst consensus and target price projections should be used in combination with other traditional techniques such as stock price forecasting, technical analysis, earnings estimate, and various momentum models.

Clene Inc stock analysis indicators help investors evaluate how Clene stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing and determine when trading Clene shares will generate the highest return on investment. By understating and applying Clene stock analysis, traders can identify Clene position entry and exit signals to maximize returns.

Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Clene Inc. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Clene. If investors know Clene will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Clene listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

The market value of Clene Inc is measured differently than its book value, which is the value of Clene that is recorded on the company's balance sheet. Investors also form their own opinion of Clene's value that differs from its market value or its book value, called intrinsic value, which is Clene's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Clene's market value can be influenced by many factors that don't directly affect Clene's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Clene's value and its price as these two are different measures arrived at by different means. Investors typically determine if Clene is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Clene's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.